XomeXBio
0801.880.687 · rovalta.com · 25/09/2026
XomeXBio
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOXomeXBio is a Private limited company incorporated in 2023. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 4,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0801.880.687
- Incorporation
- 17/05/2023
- Legal form
- Private limited company
- Registered office
- Rue Clément Ader 10
6041 Charleroi · WallonieSee on map - Contributed capital
- 298 934,42 €
- Latest accounts
- 31/12/2025
- Average workforce
- 4,0 ETP
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 103,4 k € | +312% | -48,8 k € | -602% | 9,7 k € |
| EBITDA | -252 k € | +43.7% | -447,3 k € | -12509% | -3,5 k € |
| Operating result | -731,8 k € | -6.0% | -690,5 k € | -12658% | -5,4 k € |
| Net result | -528,9 k € | +11.2% | -595,3 k € | -9293% | -6,3 k € |
| Balance sheet | |||||
| Equity | 1,1 M € | +1460% | 67,7 k € | -27.7% | 93,7 k € |
| Total assets | 3,5 M € | +130% | 1,5 M € | -17.8% | 1,9 M € |
| Cash | 82 k € | +193% | 28 k € | -98.5% | 1,8 M € |
| Debts | 2,4 M € | +67.9% | 1,5 M € | -17.3% | 1,8 M € |
| Other | |||||
| Workforce | 4,0 ETP | -16.7% | 4,8 ETP | +4700% | 0,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20255 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Rue Clément Ader 10 6041 Charleroi| Company | CBE no. |
|---|---|
2 Bridge WL● Active | 1003.906.745 |
3D Fibroscreen● Active | 1022.772.354 |
AdipoPharma Belgique● Active | 1008.146.338 |
ATRYON BELGIUM● Active | 0751.698.530 |
| 0479.250.670 | |
ConvEyXo● Active | 0725.874.259 |
CONVEYXO GROUP● Active | 1016.957.797 |
ELKEDONIA BELGIUM● Active | 1021.635.177 |
ENDO TOOLS THERAPEUTICS● Active | 0807.570.233 |
Enodia Therapeutics Belgium● Active | 1039.324.811 |
EU BIOTECH CAMPUS● Active | 0776.668.706 |
Exo-Harvest● Active | 0803.425.264 |
Hemastatx● Active | 1019.406.058 |
Immunofusion● Active | 0804.563.629 |
ImmunXperts● Active | 0552.755.587 |
INCHINN THERAPEUTICS● Active | 0799.914.755 |
INSTAR BELGIQUE● Active | 1039.395.085 |
KOKUMA● Active | 0799.078.377 |
LYS MEDICAL● Active | 0688.626.061 |
MILEUTIS● Active | 1011.400.984 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 17/05/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 |
| Length of the financial year | 12 months | 12 months | 8 months |
| Filing date | 15/07/2026 | 04/09/2025 | 30/08/2024 |
| General meeting | 01/07/2026 | 30/06/2025 | 28/08/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares22/12/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates05/12/2024DEMISSIONS, NOMINATIONS
- Mandates16/04/2024SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Other22/05/2023RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-528,9 k €↑
- 2024Annual accounts 2024-595,3 k €↓
- 2023Annual accounts 2023-6,3 k €
- 17/05/2023IncorporationPrivate limited company